Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination

Vaccine

Volumn 29, Issue 21, 2011, Pages 3728-

  Straten, Per thor ^a   Andersen, Mads Hald ^a  

^a Mental Health Center Glostrup   (Denmark)

Author keywords

Hepatitis B; IDO; Vaccination

Indexed keywords

GAMMA INTERFERON; HEPATITIS B VACCINE; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON; TRYPTOPHAN;

ADAPTIVE IMMUNITY; AMINO ACID SEQUENCE; AUTOIMMUNITY; CANCER PATIENT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HEMODIALYSIS PATIENT; HUMAN; IMMUNE RESPONSE; LETTER; LUNG NON SMALL CELL CANCER; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

DENDRITIC CELLS; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNITY, CELLULAR; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 79955086613     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.007     Document Type: Letter

References (5)

1. Eleftheriadis T., Liakopoulos V., Antoniadi G., Stefanidis I., Galaktidou G. Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination. Vaccine 2011.
2. Munn D.H., Mellor A.L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 2007, 117(May (5)):1147-1154.
3. Sorensen R.B., Berge-Hansen L., Junker N., Hansen C.A., Hadrup S.R., Schumacher T.N., et al. The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase. PLoS One 2009, 4(September (9)):e6910.
4. Sorensen R.B., Hadrup S.R., Svane I.M., Hjortso M.C., Thor S.P., Andersen M.H. Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators. Blood 2010, (November).
5. Boasso A., Herbeuval J.P., Hardy A.W., Anderson S.A., Dolan M.J., Fuchs D., et al. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007, 109(8):3351-3359.